Non-Sterile Compounding Pharmacy Companies

Latest U.S. and Europe Non-Sterile Compounding Pharmacy Companies Update

• 
  June 2023: two major industry players, BCE Pharma and PCCA, announced a cooperation to raise the bar for compounding pharmacies in Canada. Together, they will provide pharmacies in Canada third-party review services and cutting-edge technological resources for adhering to and exceeding all applicable pharmacy practice requirements. Canadian pharmacies will be given the tools they need to become compliant with regulations thanks to PCCA's partnership with BCE Pharma. Together, we can improve the quality, efficiency, and uniformity of sterile and non-sterile chemical preparation in pharmacies. Training will be provided by PCCA and BCE Pharma and will include rigorous evaluation procedures and be overseen by a staff of highly trained professionals.

• 
  June 2022: Osceola Capital, a lower middle-market private-equity company, revealed that it had acquired Wedgewood Pharmacy's human-health book of business, making it the ninth addition to the Revelation Pharma Corporation platform. Wedgewood Pharmacy runs compounding pharmacies in all 50 states, providing pet owners with sterile and non-sterile compounded pharmaceuticals. The details of the deal were kept confidential. The purchase of Wedgewood Pharmacy's book of business underscores Revelation's continuous aim to acquire and build a nationwide partnership of 503A and 503B compounding pharmacies and Wedgewood Pharmacy's strategy to focus on compounding exclusively for animal health in its compounding pharmacies. When mass-produced pharmaceuticals are either not accessible or not suited for a patient, compounded medications are developed and made by properly educated pharmacists and pharmacy technicians in pharmacies governed by the state.

• Fagron (the Netherlands)


• B.Braun Melsungen AG (Germany)


• Fresenius Kabi AG (Germany)


• TRUE NATURE HOLDING, INC (U.S)


• Dougherty's Pharmacy Inc. (U.S.)


• PHARMEDIUM (U.S.)